OpenLB
Open Library of Bioscience
Advanced Search

Expert Opinion On Drug Discovery

Journal Information
Journal Abbr. Expert Opin Drug Dis
Web of Sciences Category
Pharmacology & Pharmacy
Print ISSN 1746-0441
E-ISSN 1746-045X
NLM Catelog ID 101295755
Scopus Source ID 6800153101
Country ENGLAND
Language English
Publisher Taylor & Francis Ltd
Publisher Address 2-4 Park Square, Milton Park, Abingdon, England, Oxon, Ox14 4rn

Related Publications

Found 2,015 results

The reality of modeling irritable bowel syndrome: progress and challenges.
Maryam S Fakhri Bafghi, Niloofar Khoshnam Rad, Ghazal Roostaei, Shekoufeh Nikfar, Mohammad Abdollahi
Expert Opin Drug Discov. Apr, 2025.20(4):433-445 Print-Electronic
Source:PubMed
PMID: 40162721 doi:10.1080/17460441.2025.2481264
Drug repurposing in amyotrophic lateral sclerosis (ALS).
Emily Carroll, Jakub Scaber, Kilian V M Huber, Paul E Brennan, Alexander G Thompson, Martin R Turner, Kevin Talbot
Expert Opin Drug Discov. Apr, 2025.20(4):447-464 Print-Electronic
Source:PubMed
PMID: 40029669 doi:10.1080/17460441.2025.2474661
A comprehensive update on the use of molecular topology applications for anti-infective drug discovery.
Beatriz Suay-Garc��a, Joan Climent, Mar��a Teresa P��rez-Gracia, Antonio Falc��
Expert Opin Drug Discov. Apr, 2025.20(4):465-474 Print-Electronic
Source:PubMed
PMID: 40056200 doi:10.1080/17460441.2025.2477625
The ongoing challenge of slowing ageing through drug discovery.
David G Le Couteur, Stephen J Simpson, Victoria C Cogger, Janani Thillainadesan, Rozalyn Anderson, Rafael de Cabo
Expert Opin Drug Discov. Apr, 2025.20(4):401-404 Print-Electronic
Source:PubMed
PMID: 40099655 doi:10.1080/17460441.2025.2482063
Innovative strategies for the discovery of new drugs against androgenetic alopecia.
Kevin J McElwee, John P Sundberg
Expert Opin Drug Discov. Apr, 2025.20(4):517-536 Print-Electronic
Source:PubMed
PMID: 40029254 doi:10.1080/17460441.2025.2473905
Advances in the design, discovery, and optimization of aurora kinase inhibitors as anticancer agents.
Anubhav Verma, Pradhuman Bharatiya, Aashish Jaitak, Vaibhav Nigam, Vikramdeep Monga
Expert Opin Drug Discov. Apr, 2025.20(4):475-497 Print-Electronic
Source:PubMed
PMID: 40094219 doi:10.1080/17460441.2025.2481272
Embracing the changes and challenges with modern early drug discovery.
Vinay Kumar, Kunal Roy
Expert Opin Drug Discov. Apr, 2025.20(4):419-431 Print-Electronic
Source:PubMed
PMID: 40098331 doi:10.1080/17460441.2025.2481259
The preclinical discovery and development of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa.
Klaudia Knecht-Gurwin, Lukasz Matusiak, Jacek C Szepietowski
Expert Opin Drug Discov. Apr, 2025.20(4):405-417 Print-Electronic
Source:PubMed
PMID: 40106842 doi:10.1080/17460441.2025.2482058
Revisiting experimental models of erectile dysfunction and their value in drug discovery and development.
Hao Wang, Eric Chung
Expert Opin Drug Discov. Apr, 2025.20(4):499-516 Print-Electronic
Source:PubMed
PMID: 40110856 doi:10.1080/17460441.2025.2482065
Advances in next-generation sequencing (NGS) applications in drug discovery and development.
Huihong Wang, Jiale Huang, Xianfu Fang, Mengyao Liu, Xiaohong Fan, Yizhou Li
Expert Opin Drug Discov. Apr, 2025.20(4):537-550 Print-Electronic
Source:PubMed
PMID: 40099494 doi:10.1080/17460441.2025.2481262